MYD88 and arthritic joint disease: Rather, we have addressed translational potential by designing a library of SMAs of which at least two (11a, 12b) mimic ES-62’s primary mechanism of action in downregulating MyD88 and also recapitulate many of its protective effects in mouse models of chronic inflammatory disease including asthma, arthritis and SLE (10, 32, 54).